Stock Information
Protagonist Therapeutics Inc (PTGX)
Ticker Symbol: PTGX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $6,087.99 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -1.8038
Revenue (TTM): $1.05 M
Dividend Yield: N/A%
ROE: -17.76%
Latest News
-
Protagonist Therapeutics (NASDAQ:PTGX) Shows Technical Strength and High Growth Momentum
Sat, Jun 13, 2026 9:30 AM
-
Protagonist Therapeutics: A Royalty-Driven Biotech With Two Shots On Goal
Sat, Jun 13, 2026 8:46 AM
-
Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data
Fri, Jun 12, 2026 10:47 AM
Key Financials
Financial data not available
